首页 | 本学科首页   官方微博 | 高级检索  
     

Xp11.2易位/TFE3基因融合相关性肾癌临床分析(附12例)
引用本文:张 涛1,冯莉娟2,柯昌兴1. Xp11.2易位/TFE3基因融合相关性肾癌临床分析(附12例)[J]. 现代肿瘤医学, 2022, 0(22): 4142-4146. DOI: 10.3969/j.issn.1672-4992.2022.22.023
作者姓名:张 涛1  冯莉娟2  柯昌兴1
作者单位:1.昆明医科大学第二附属医院泌尿外科;2.核医学科,云南 昆明 650101
摘    要:目的:探讨Xp11.2易位/TFE3基因融合相关性肾癌的临床特征,提高对该病的认识。方法:回顾性分析我院2015年01月至2020年12月术后经病理证实的12例Xp11.2易位/TFE3基因融合相关性肾癌患者的临床资料。结果:临床表现为肉眼血尿2例,腰部疼痛5例,体检发现肾脏占位2例,血尿伴腹痛1例,血尿伴腰痛1例,腹部疼痛1例,病程为5天~8年。术后病理均诊断为Xp11.2易位/TFE3基因融合相关性肾癌;肿瘤直径范围2.0~12.0 cm,镜下见大量透明细胞呈乳头状、腺泡样分布,可伴砂粒体形成;12例免疫组织化学检查均为TFE3阳性,CD10阳性率为91.7%(11/12),Vimentin阳性率为66.7%(8/12),P504S阳性率为66.7%(8/12),EMA、CK7、CK8呈不同程度阳性表达。结论:Xp11.2易位/TFE3基因融合相关性肾癌好发于儿童和青年,临床表现主要为肉眼血尿和腰部疼痛,影像学检查有助于其术前诊断及鉴别诊断,目前临床诊断主要依靠免疫组化检测TFE3表达水平。

关 键 词:肾癌  Xp11.2易位  TFE3基因融合

Clinical analysis of 12 cases of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion
ZHANG Tao1,FENG Lijuan2,KE Changxing1. Clinical analysis of 12 cases of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion[J]. Journal of Modern Oncology, 2022, 0(22): 4142-4146. DOI: 10.3969/j.issn.1672-4992.2022.22.023
Authors:ZHANG Tao1  FENG Lijuan2  KE Changxing1
Affiliation:1.Department of Urology;2.Department of Nuclear Medicine,the Second Affiliated Hospital of Kunming Medical University,Yunnan Kunming 650101,China.
Abstract:Objective:To explore the clinical characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion,and to improve the understanding of the disease.Methods:The clinical data of 12 patients with Xp11.2 translocation/TFE3 gene fusion-related renal cell carcinoma confirmed by pathology in our hospital from January 2015 to December 2020 were retrospectively analyzed.Results:The clinical manifestations included 2 cases of gross hematuria,5 cases of lumbar pain,2 cases of kidney occupying,1 case of hematuria with abdominal pain,1 case of hematuria with low lumbar pain,and 1 case of abdominal pain.The course of the disease lasted from 5 days to 8 years.Postoperative pathology was diagnosed as Xp11.2 translocation/TFE3 gene fusion-related renal cell carcinoma.Tumor diameter ranged from 2.0 to 12.0 cm,and a large number of clear cells were seen under the microscope,which were papillary and acinar-like distribution,and may be accompanied by sand granule formation.All cases of immunohistochemical examination were positive TFE3.CD10 positive rate was 91.7% (11/12).Vimentin positive rate was 66.7% (8/12).P504S positive rate was 66.7% (8/12).EMA,CK7,CK8 showed different degrees of positive expression.Conclusion:Xp11.2 translocation/TFE3 gene fusion-associated renal cell carcinoma is more likely to occur in children and young adults.The clinical manifestations are mainly gross hematuria and lumbar pain.Imaging examination is helpful for its preoperative diagnosis and differential diagnosis.The current clinical diagnosis mainly relies on immunohistochemistry to detect TFE3 expression level.
Keywords:renal cell carcinoma   Xp11.2 translocation   TFE3 gene fusion
本文献已被 维普 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号